Approvals are a subset of commitments for which funding availability and programme performance has been assessed as satisfactory. Only such approved amounts can be disbursed subject to all other conditions for disbursement being met by the countries. Approvals are typically granted for the current year and one further year.
Commitments represent endorsements of multi-year programme budgets made by the Gavi Board, Executive Committee or the CEO. These endorsements do not constitute a liability to pay but instead send a positive signal that Gavi intends to fund a programme over its entire life span subject to performance and availability of funds.
Disbursements by 'Programme Year' in the graph shows the payments made from 2020 up to the date of the report. The payments are shown by the programme year to which they relate irrespective of the calendar year in which they were made. The programme year is the year in which the relevant vaccine/cash programme is being implemented.
Annual figures may reflect negative values due to refunds from previous years or allocation of prepayments to reflect actual apportionment by country.
Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
This Gavi country data is made available under the Creative Commons BY 4.0 license: https://creativecommons.org/licenses/by/4.0/
Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years.
COVID-19 through the lens of a Ghanaian photographer
While the pandemic forced everyone else indoors, a Ghanaian photographer took to the streets to document Accra on lockdown.
“At last”: Ghanaian football star Michael Essien hails world’s first malaria vaccine
Years before Michael Essien began his extraordinary Premier League football career, he was a barefoot kid in small-town Ghana, scoring between goalposts made of stacked rocks. Like millions of other children in the world’s endemic zones, young…
Gavi Board approves funding to support malaria vaccine roll-out in sub-Saharan Africa
A new malaria vaccination programme will support Gavi-eligible countries to implement a new tool in the fight against malaria in sub-Saharan Africa in 2022-2025, including vaccine introduction, procurement and delivery
A Ghanaian doctor’s perspective on COVID-19 vaccine inequity
Pre-COVID-19, Ghana’s health system was overburdened. The virus has made everything harder, and vaccine inequity has made it harder still.
Discoveries from vaccine implementation
In episode 8 of the Global Health Matters podcast, we spoke to Professor Margaret Gyapong of the University of Health and Allied Sciences in Ghana and Dr Lee Hampton of Gavi, the Vaccine Alliance. These experts shared their views on how…
In Ghana, a strong cold chain makes all the difference
UNICEF and Gavi partnered to fund, procure and deliver more than 2,300 items of cold chain equipment to ensure health centres met immunization targets.
Bringing routine immunisation back into focus in Ghana
Community health nurses in Ghana are on a mission to reverse the decline in routine immunisation since the start of the COVID-19 pandemic.
Gavi, Unitaid and the Global Fund welcome WHO recommendation for world’s first malaria vaccine
WHO recommendation for wider use of the RTS,S malaria vaccine is largely based on data gathered during malaria vaccine pilots which took place in Kenya, Ghana and Malawi
Name | Source | Date |
---|---|---|
Total population | United Nations, World Population Prospects (UN WPP), July 2024 release. | 2024-07-11 |
Birth cohort (Total number of live births) | United Nations, World Population Prospects (UN WPP), July 2024 release. | 2024-07-11 |
Surviving infants (# of children surviving to 1 year) | United Nations, World Population Prospects (UN WPP), July 2024 release. | 2024-07-11 |
Infant mortality rate (deaths < 1 year per 1000 births) | UN Inter-agency Group for Child Mortality Estimation (UN IGME), March 2024 release. | 2024-04-15 |
Child mortality rate (deaths < 5 years per 1000 births) | UN Inter-agency Group for Child Mortality Estimation (UN IGME), March 2024 release. | 2024-04-15 |
GNI per capita, Atlas method (current US$) | World Bank national accounts data, and OECD National Accounts data files, July 2024 release. | 2024-07-01 |
Number of zero-dose children | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release; figures calculated using number of surviving infants from UN World Population Prospects (UN WPP) | 2024-07-15 |
% reduction in number of zero-dose children, 2019-2023 | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release; figures calculated using number of surviving infants from UN World Population Prospects (UN WPP) | 2024-07-15 |
DTP1/DTP3/MCV1 coverage (%) | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release. | 2024-07-15 |
Drop out from DTP1 to DTP3 | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release | 2024-07-15 |
Drop out from DTP1 to last routine dose of MCV | WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), July 2024 release. | 2024-07-15 |
Geographic equity of DTP3 coverage: DTP3 coverage in the 20% of districts with lowest coverage | WHO/UNICEF Joint Reporting Form (JRF), July 2024 release. | 2024-07-05 |